相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZODIAC)
R. S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Voriconazole Increases while Itraconazole Decreases Plasma Meloxicam Concentrations
V. V. Hynninen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects
Nassr Nassr et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects
N. A. Farid et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Effect of itraconazole on the pharmacokinetics of imidafenacin in healthy subjects
Tomoya Ohno et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors
Tomohide Tamura et al.
JOURNAL OF THORACIC ONCOLOGY (2006)
Vascular endothelial growth factor signaling pathways: Therapeutic perspective
Marcin Kowanetz et al.
CLINICAL CANCER RESEARCH (2006)
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors
SN Holden et al.
ANNALS OF ONCOLOGY (2005)
Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol
HC Swaisland et al.
CLINICAL PHARMACOKINETICS (2005)
Rifampicin, a keystone inducer of drug metabolism: From Herbert Remmer's pioneering ideas to modern concepts
HM Bolt
DRUG METABOLISM REVIEWS (2004)
Novel 4-anilinoquinazolines with C-7 basic side chains:: Design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors
LF Hennequin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance
K Venkatakrishnan et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
